Stay updated on Cusatuzumab Combo for AML Clinical Trial
Sign up to get notified when there's something new on the Cusatuzumab Combo for AML Clinical Trial page.

Latest updates to the Cusatuzumab Combo for AML Clinical Trial page
- Check5 days agoChange DetectedThe record history shows a new Revision: v3.6.3 replacing v3.6.2, indicating a small platform update. No study data or content are altered.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page's Revision indicator was updated from v3.6.0 to v3.6.2, reflecting a newer build of the history interface.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedIn the latest history entry, the study is shown as no longer looking for participants, indicating that recruitment has ceased. The version also adds the revision label v3.6.0 and removes the previous label v3.5.5.SummaryDifference0.2%

- Check34 days agoChange DetectedThe history log now shows the latest page revision as v3.5.5, replacing the previous v3.5.4 entry. This reflects an update to the page's version history rather than changes to the study data.SummaryDifference0.1%

- Check55 days agoChange DetectedA new version entry (41) appears in the Record History with Study Status updates. The revision tag was updated to Revision: v3.5.4 on 2026-05-12, replacing the previous revision.SummaryDifference0.3%

- Check70 days agoChange DetectedThe page history now shows the latest revision as v3.5.3, replacing the previous v3.5.2. This reflects an update to the page's revision history rather than substantive changes to study details.SummaryDifference0.1%

Stay in the know with updates to Cusatuzumab Combo for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cusatuzumab Combo for AML Clinical Trial page.